GREY:ATBPF - Post by User
Post by
Ryeman40on Mar 30, 2021 3:00pm
277 Views
Post# 32907470
Clinical Trials
Clinical TrialsJust for Osteoarthritis there are 73 clinical trials in the USA. From phase 1-3 and includes injections, patches, oral, and stromal cells. This tells me that there is a lot of interest in this field still. BP will pay if this problem is ever solved. Some help with the pain but there is not one that helps with pain and is safe to take at the same time. I've wondered for months what a breakthrough like this would mean to the pharmaceutical world and more importantly to the patient. Being a large shareholder, i would say 4 billion just for OTENA. The other indication for OTENA is rheumatoid arthritis. The global market for Rheumatoid is projected to be 34 billion by 2025. Every BP is in this segment. Pfizer, Eli Lilly, Bristol-Myers Squibb, Gilead, Amgen, and more. Not Bayer though hmmmmm.